256 related articles for article (PubMed ID: 25008933)
21. Point mutations in exon I of the herpes simplex virus putative terminase subunit, UL15, indicate that the most conserved residues are essential for cleavage and packaging.
Przech AJ; Yu D; Weller SK
J Virol; 2003 Sep; 77(17):9613-21. PubMed ID: 12915573
[TBL] [Abstract][Full Text] [Related]
22. Interaction of herpes simplex virus type 1 DNA polymerase and the UL42 accessory protein with a model primer template.
Gottlieb J; Challberg MD
J Virol; 1994 Aug; 68(8):4937-45. PubMed ID: 8035492
[TBL] [Abstract][Full Text] [Related]
23. Murine cytomegalovirus resistant to antivirals has genetic correlates with human cytomegalovirus.
Scott GM; Ng HL; Morton CJ; Parker MW; Rawlinson WD
J Gen Virol; 2005 Aug; 86(Pt 8):2141-2151. PubMed ID: 16033961
[TBL] [Abstract][Full Text] [Related]
24. Single nucleotide polymorphisms of thymidine kinase and DNA polymerase genes in clinical herpes simplex virus type 1 isolates associated with different resistance phenotypes.
Schubert A; Gentner E; Bohn K; Schwarz M; Mertens T; Sauerbrei A
Antiviral Res; 2014 Jul; 107():16-22. PubMed ID: 24747042
[TBL] [Abstract][Full Text] [Related]
25. Two-Metal Ion-Dependent Enzymes as Potential Antiviral Targets in Human Herpesviruses.
DiScipio KA; Weerasooriya S; Szczepaniak R; Hazeen A; Wright LR; Wright DL; Weller SK
mBio; 2022 Feb; 13(1):e0322621. PubMed ID: 35073739
[TBL] [Abstract][Full Text] [Related]
26. A point mutation in the human cytomegalovirus DNA polymerase gene selected in vitro by cidofovir confers a slow replication phenotype in cell culture.
Cihlar T; Fuller MD; Mulato AS; Cherrington JM
Virology; 1998 Sep; 248(2):382-93. PubMed ID: 9721246
[TBL] [Abstract][Full Text] [Related]
27. Drug Susceptibility and Replicative Capacity of Multidrug-Resistant Recombinant Human Cytomegalovirus Harboring Mutations in
Piret J; Goyette N; Boivin G
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807919
[TBL] [Abstract][Full Text] [Related]
28. Characterization of a thiourea derivative that targets viral transactivators of cytomegalovirus and herpes simplex virus type 1.
Kondo H; Koshizuka T; Majima R; Takahashi K; Ishioka K; Suzutani T; Inoue N
Antiviral Res; 2021 Dec; 196():105207. PubMed ID: 34774602
[TBL] [Abstract][Full Text] [Related]
29. ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2.
Chono K; Katsumata K; Kontani T; Kobayashi M; Sudo K; Yokota T; Konno K; Shimizu Y; Suzuki H
J Antimicrob Chemother; 2010 Aug; 65(8):1733-41. PubMed ID: 20534624
[TBL] [Abstract][Full Text] [Related]
30. Definition of herpes simplex virus type 1 helper activities for adeno-associated virus early replication events.
Alazard-Dany N; Nicolas A; Ploquin A; Strasser R; Greco A; Epstein AL; Fraefel C; Salvetti A
PLoS Pathog; 2009 Mar; 5(3):e1000340. PubMed ID: 19282980
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive Mutagenesis of Herpes Simplex Virus 1 Genome Identifies UL42 as an Inhibitor of Type I Interferon Induction.
Chapon M; Parvatiyar K; Aliyari SR; Zhao JS; Cheng G
J Virol; 2019 Dec; 93(23):. PubMed ID: 31511375
[TBL] [Abstract][Full Text] [Related]
32. The pre-NH(2)-terminal domain of the herpes simplex virus 1 DNA polymerase catalytic subunit is required for efficient viral replication.
Terrell SL; Coen DM
J Virol; 2012 Oct; 86(20):11057-65. PubMed ID: 22875965
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of herpes simplex virus replication by a 2-amino thiazole via interactions with the helicase component of the UL5-UL8-UL52 complex.
Spector FC; Liang L; Giordano H; Sivaraja M; Peterson MG
J Virol; 1998 Sep; 72(9):6979-87. PubMed ID: 9696789
[TBL] [Abstract][Full Text] [Related]
34. Effective deploying of a novel DHODH inhibitor against herpes simplex type 1 and type 2 replication.
Luganini A; Sibille G; Mognetti B; Sainas S; Pippione AC; Giorgis M; Boschi D; Lolli ML; Gribaudo G
Antiviral Res; 2021 May; 189():105057. PubMed ID: 33716051
[TBL] [Abstract][Full Text] [Related]
35. Analysis of in vitro activities of herpes simplex virus type 1 UL42 mutant proteins: correlation with in vivo function.
Thornton KE; Chaudhuri M; Monahan SJ; Grinstead LA; Parris DS
Virology; 2000 Sep; 275(2):373-90. PubMed ID: 10998337
[TBL] [Abstract][Full Text] [Related]
36. Gene polymorphism of thymidine kinase and DNA polymerase in clinical strains of herpes simplex virus.
Bohn K; Zell R; Schacke M; Wutzler P; Sauerbrei A
Antivir Ther; 2011; 16(7):989-97. PubMed ID: 22024514
[TBL] [Abstract][Full Text] [Related]
37. Increased transcomplementation properties of plasmids carrying HSV-1 origin of replication and packaging signals.
Berthomme H; Fournel S; Epstein AL
Virology; 1996 Feb; 216(2):437-43. PubMed ID: 8607275
[TBL] [Abstract][Full Text] [Related]
38. Characterization of drug resistance-associated mutations in the human cytomegalovirus DNA polymerase gene by using recombinant mutant viruses generated from overlapping DNA fragments.
Cihlar T; Fuller MD; Cherrington JM
J Virol; 1998 Jul; 72(7):5927-36. PubMed ID: 9621055
[TBL] [Abstract][Full Text] [Related]
39. [Analysis of mutations in DNA polymerase and thymidine kinase genes of herpes simplex virus clinical isolates resistant to antiherpetic drugs].
Korovina AN; Gus'kova AA; Skoblov MIu; Andronova VL; Galegov GA; Kochetkov SN; Kukhanova MK; Skoblov IuS
Mol Biol (Mosk); 2010; 44(3):488-96. PubMed ID: 20608173
[TBL] [Abstract][Full Text] [Related]
40. Distribution and effects of amino acid changes in drug-resistant α and β herpesviruses DNA polymerase.
Topalis D; Gillemot S; Snoeck R; Andrei G
Nucleic Acids Res; 2016 Nov; 44(20):9530-9554. PubMed ID: 27694307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
